GO
Loading...

Enter multiple symbols separated by commas

Food and Staples Retailing Drug Retail

More

  • 'Female Viagra' sparks interest in Valeant Thursday, 20 Aug 2015 | 8:00 AM ET
    'Female Viagra' sparks interest in Valeant

    Valeant to purchase flibanserin-maker Sprout for $1 billion.

  • 'Female Viagra' hits the markets this fall Wednesday, 19 Aug 2015 | 10:00 AM ET
    'Female Viagra' hits the markets this fall

    The FDA approved the first prescription drug for enhancing female libido.

  • Wal-Mart Stores Inc said on Tuesday that lower margins in its pharmacy business had emerged as a drag on profits, as it gets paid less by drug plan managers and as fewer customers pay in cash, since Obamacare has increased the ranks of insured Americans. The company warned that the margin squeeze would continue for at least the remainder of the year, although a...

  • Aug 18- Wal-Mart Stores Inc reported weaker quarterly earnings and lowered its annual forecast on Tuesday, as it copes with higher labor costs, a squeeze on pharmacy margins and sliding sales at its British supermarket chain. Net profit attributable to Wal-Mart fell to $3.48 billion, or $1.08 per share, in the second quarter ended July 31, from $3.92 billion, or...

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its annual forecast on Tuesday, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. Wal-Mart lowered its forecast for the year ending in January to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05 in February.

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast, citing higher costs from adding worker hours as well as weaker margins in its U.S. pharmacy business. For the year ending in January, Wal-Mart lowered its earnings-per-share forecast to a range of $4.40 to $4.70 from its outlook of $4.70 to $5.05...

  • Aug 18- Wal-Mart Stores Inc reported weaker-than-expected quarterly earnings and lowered its full-year forecast on Tuesday, citing investments in staffing and weaker margins in its U.S. pharmacy business. Net profit attributable to Wal-Mart fell to $1.08 per share, in the second quarter ended July 31 from $1.21 per share, a year earlier.

  • The Spark: FDA approves first 3-D printed drugs Thursday, 13 Aug 2015 | 4:50 PM ET
    The Spark: FDA approves first 3-D printed drugs

    Don Weatherhold, Aprecia Pharmaceuticals CEO, discusses Aprecia and the technology of 3-D printing and prescription drugs.

  • Rite Aid to accept Apple Pay and Google Wallet Tuesday, 11 Aug 2015 | 5:25 PM ET
    Apple Pay

    The drugstore is expanding to accept Apple Pay and Google Wallet Saturday after slashing support last year. Re/code reports.

  • Mobile payments for Rite Aid Tuesday, 11 Aug 2015 | 10:00 AM ET
    Mobile payments for Rite Aid

    Rite Aid to start accepting mobile payments this Saturday.

  • CVS drops Pfizer's Viagra Wednesday, 5 Aug 2015 | 1:14 PM ET
    CVS drops Pfizer's Viagra

    CVS says Pfizer's Viagra will no longer be an approved formula in 2016, reports CNBC's Bertha Coombs.

  • Aug 4- U.S. drugstore chain operator CVS Health Corp estimated current-quarter profit below analysts' expectations, hurt by pressure from reimbursement rates and lower customer traffic after the company stopped selling tobacco products. The company forecast adjusted profit of $1.27- $1.30 per share for the third quarter. The company also raised the lower...

  • *Walt Disney, Genworth to report after the bell. Aug 4- Wall Street was little changed on Tuesday amid a burst of earnings reports from companies ranging from drugstore operator CVS Health to handbag maker Coach, while Apple's shares remained under pressure for a second day. Among other companies scheduled to release results are Dow component Walt Disney, Devon...

  • Viagra shot? China probes sex drug-spiked liquor Sunday, 2 Aug 2015 | 8:38 PM ET
    Viagra pill

    Chinese police are investigating if two distillers added impotence treatment drug Viagra to their liquor in the latest food-safety scare in China.

  • Doctors fight to lower cancer drugs cost Friday, 24 Jul 2015 | 3:19 PM ET
    Doctors fight to lower cancer drugs cost

    Amid rising health care and drug costs, a group of doctors at the Mayo Clinic is trying to lower the costs of cancer treatments for patients. Insight, with Dr. Ayalew Tefferi, Mayo Clinic.

  • July 17- University of California Health, which runs four hospitals in the university's campuses, and drug retailer CVS Health Corp's CVSphoto.com became the latest victims of cyber attacks. UCLA Health said on Friday that data on as many as 4.5 million individuals was at potentially at risk, although it added it had not yet found evidence that individuals'...

  • What to expect from US June retail sales Monday, 13 Jul 2015 | 6:19 PM ET
    What to expect from US June retail sales

    Lindsey Bell, Senior Analyst at S&P Capital IQ, explains why she's expecting a monthly increase of 0.3 percent.

  • Euro zone leaders made Greece surrender much of its sovereignty to outside supervision in return for talks on an 86- billion-euro bailout to keep the near-bankrupt country within the single currency union. Drugstore chain CVS Health also came to market with a bond sale of up to $15 billion to finance its acquisitions of Omnicare and Target Pharmacies,...

  • July 9- Walgreens Boots Alliance Inc, the largest U.S. drug store chain, raised its full-year profit forecast on Thursday and said acting Chief Executive Officer Stefano Pessina will take over on a permanent basis. The company said it is on track to reach its target of at least $650 million net synergies in fiscal year 2015 from the merger and $1 billion in fiscal...

  • July 9- Drugstore chain Walgreens Boots Alliance Inc, formed by Walgreens' takeover of Europe's Alliance Boots in December, reported a better-than-expected quarterly profit, helped by higher prescription sales and lower costs. Walgreens Boots Alliance also bought Avon Products Inc's U.K.- based Liz Earle skincare business for 140 million pounds.